Planet 13 Holdings (PLNH) Enterprise Value (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Enterprise Value came in at -$16.3 million in Q1 2026, up 7.67% year-on-year from -$15.1 million in Q1 2025, and down 4.38% on a QoQ basis from -$15.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Enterprise Value (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Enterprise Value data on file, last reported at -$16.3 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 7.67% year-over-year to -$16.3 million in Q1 2026; TTM through Mar 2026 was -$16.3 million, a 7.67% increase from a year earlier, with the FY2025 full-year figure at -$15.6 million, up 38.77% from the prior year.
- Enterprise Value for Q1 2026 stood at -$16.3 million, down from -$15.6 million in the prior quarter.
- Over the last five years, Enterprise Value for PLNH reached as high as -$15.6 million in Q4 2025 and fell as low as -$62.1 million in Q1 2022.
- Historically, Enterprise Value has averaged -$28.4 million across 5 years, with a median of -$24.5 million in 2023.
- On a YoY basis, Enterprise Value climbed as much as 61.39% in 2022 and fell as far as 37349.39% in 2022.
- Year by year, Enterprise Value stood at -$38.8 million in 2022, then jumped by 55.45% to -$17.3 million in 2023, then plunged by 47.18% to -$25.4 million in 2024, then soared by 38.77% to -$15.6 million in 2025, then decreased by 4.38% to -$16.3 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$16.3 million in Q1 2026, -$15.6 million in Q4 2025, and -$17.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -16.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.26 Mn |
| Dec 31, 2025 | -15.58 Mn |
| Sep 30, 2025 | -17.18 Mn |
| Jun 30, 2025 | -15.85 Mn |
| Mar 31, 2025 | -17.61 Mn |
| Dec 31, 2024 | -25.44 Mn |
| Sep 30, 2024 | -29.46 Mn |
| Jun 30, 2024 | -28.72 Mn |
| Mar 31, 2024 | -22.82 Mn |
| Dec 31, 2023 | -17.28 Mn |
| Sep 30, 2023 | -20.49 Mn |
| Jun 30, 2023 | -24.46 Mn |
| Mar 31, 2023 | -26.92 Mn |
| Dec 31, 2022 | -38.79 Mn |
| Sep 30, 2022 | -50.88 Mn |
| Jun 30, 2022 | -52.62 Mn |
| Mar 31, 2022 | -62.14 Mn |
| Dec 31, 2021 | -58.59 Mn |
| Sep 30, 2021 | -1.62 Mn |
| Jun 30, 2021 | -136.29 Mn |